These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9299164)

  • 1. In vitro modulation of implantation and intraepithelial expansion of bladder tumor cells by epidermal growth factor.
    Bindels EM; Vermey M; Rebel JM; Zwarthoff EC; Van Der Kwast TH
    Exp Cell Res; 1997 Sep; 235(2):395-402. PubMed ID: 9299164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
    Messing EM
    Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-cadherin expression determines the mode of replacement of normal urothelium by human bladder carcinoma cells.
    Rebel JM; Thijssen CD; Vermey M; Delouvée A; Zwarthoff EC; Van der Kwast TH
    Cancer Res; 1994 Oct; 54(20):5488-92. PubMed ID: 7923182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-cadherin promotes intraepithelial expansion of bladder carcinoma cells in an in vitro model of carcinoma in situ.
    Bindels EM; Vermey M; van den Beemd R; Dinjens WN; Van Der Kwast TH
    Cancer Res; 2000 Jan; 60(1):177-83. PubMed ID: 10646871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro model of urothelial regeneration: effects of growth factors and extracellular matrix proteins.
    Rebel JM; De Boer WI; Thijssen CD; Vermey M; Zwarthoff EC; Van der Kwast TH
    J Pathol; 1994 Jul; 173(3):283-91. PubMed ID: 7523645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth of normal and neoplastic urothelium and response to epidermal growth factor in a defined serum-free medium.
    Dubeau L; Jones PA
    Cancer Res; 1987 Apr; 47(8):2107-12. PubMed ID: 3493840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of intra-epithelial expansion of human T24 bladder-carcinoma cells in murine urothelium by growth factors and extracellular-matrix components.
    Rebel JM; Thijssen CD; Vermey M; Zwarthoff EC; Van der Kwast TH
    Int J Cancer; 1995 Mar; 60(5):707-11. PubMed ID: 7532160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of distinct functions for growth factors in murine transitional epithelial cells in primary organotypic culture.
    de Boer WI; Rebel JM; Vermey M; de Jong AA; van der Kwast TH
    Exp Cell Res; 1994 Oct; 214(2):510-8. PubMed ID: 7925644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
    Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
    Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth.
    Cheng J; Huang H; Zhang ZT; Shapiro E; Pellicer A; Sun TT; Wu XR
    Cancer Res; 2002 Jul; 62(14):4157-63. PubMed ID: 12124355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functions of epidermal growth factor-like growth factors during human urothelial reepithelialization in vitro and the role of erbB2.
    Bindels EM; van der Kwast TH; Izadifar V; Chopin DK; de Boer WI
    Urol Res; 2002 Sep; 30(4):240-7. PubMed ID: 12202942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine regulation of human urothelial cell proliferation and migration during regenerative responses in vitro.
    Varley C; Hill G; Pellegrin S; Shaw NJ; Selby PJ; Trejdosiewicz LK; Southgate J
    Exp Cell Res; 2005 May; 306(1):216-29. PubMed ID: 15878346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine acidification has no effect on peroxisome proliferator-activated receptor (PPAR) signaling or epidermal growth factor (EGF) expression in rat urinary bladder urothelium.
    Achanzar WE; Moyer CF; Marthaler LT; Gullo R; Chen SJ; French MH; Watson LM; Rhodes JW; Kozlosky JC; White MR; Foster WR; Burgun JJ; Car BD; Cosma GN; Dominick MA
    Toxicol Appl Pharmacol; 2007 Sep; 223(3):246-56. PubMed ID: 17663016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of urine on clonal growth of human bladder cancer cell lines.
    Kuranami M; Yamaguchi K; Fuchigami M; Imanishi K; Watanabe T; Abe K; Asanuma F; Hiki Y
    Cancer Res; 1991 Sep; 51(17):4631-5. PubMed ID: 1873808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NS-398, a selective cyclooxygenase-2 inhibitor, reduces experimental bladder carcinoma outgrowth by inhibiting tumor cell proliferation.
    Smakman N; Schaap N; Snijckers CM; Borel Rinkes IH; Kranenburg O
    Urology; 2005 Aug; 66(2):434-40. PubMed ID: 16098373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
    Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
    Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of denuded urothelium in bladder biopsy.
    Levi AW; Potter SR; Schoenberg MP; Epstein JI
    J Urol; 2001 Aug; 166(2):457-60. PubMed ID: 11458047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of invasiveness in organotypic cultures after NBT-II rat bladder carcinoma stimulation with in vitro scattering factors.
    Tucker GC; Delouvée A; Jouanneau J; Gavrilovic J; Moens G; Vallés AM; Thiery JP
    Invasion Metastasis; 1991; 11(6):297-309. PubMed ID: 1726609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal and malignant human urothelium: in vitro effects of epidermal growth factor.
    Messing EM; Reznikoff CA
    Cancer Res; 1987 May; 47(9):2230-5. PubMed ID: 3494507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.